Company profile for VolitionRx

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Volition is a multi-national healthcare company passionate about revolutionizing early disease detection for humans and animals. We are developing simple, cost-effective tests that measure nucleosomes circulating in the blood to identify cancer and other diseases early, even before symptoms appear. Our mission is simple, we want to save lives, and by making disease screening as simple, low cost and as routine as cholesterol or...
Volition is a multi-national healthcare company passionate about revolutionizing early disease detection for humans and animals. We are developing simple, cost-effective tests that measure nucleosomes circulating in the blood to identify cancer and other diseases early, even before symptoms appear. Our mission is simple, we want to save lives, and by making disease screening as simple, low cost and as routine as cholesterol or pregnancy testing we believe we can help to detect disease sooner. We’re excited to have launched our first product from our veterinary subsidiary, Volition Veterinary.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
22 Rue Phocas Lejeune Parc Scientifique Crealys 5032 Isnes
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/volition-solves-liquid-biopsys-needle-in-a-haystack-problem-achieves-180-fold-18-000-enrichment-302639218.html

PR NEWSWIRE
11 Dec 2025

https://www.prnewswire.com/news-releases/volitionrx-limited-announces-inclusion-of-its-nuq-nets-assay-as-innovative-biomarker-in-frances-real-world-evaluation-of-early-detection-of-sepsis-302632912.html

PR NEWSWIRE
04 Dec 2025

https://www.prnewswire.com/news-releases/volitionrx-limited-announces-the-first-sale-of-the-nuq-cancer-assays-for-clinical-certification-in-preparation-for-routine-clinical-use-302625594.html

PR NEWSWIRE
25 Nov 2025

https://www.prnewswire.com/news-releases/volitionrx-limited-announces-pricing-of-6-0-million-underwritten-public-offering-of-common-stock-and-common-stock-warrants-302580778.html

PR NEWSWIRE
10 Oct 2025

https://www.prnewswire.com/news-releases/volitionrx-limited-announces-proposed-underwritten-public-offering-of-common-stock-and-common-stock-warrants-302580186.html

PR NEWSWIRE
09 Oct 2025

https://www.prnewswire.com/news-releases/volition-signs-co-marketing-and-services-agreement-with-hologic-302569548.html

PR NEWSWIRE
29 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty